Article
Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?
European journal of pharmacology - 30 Jan 2013
Hemmeryckx Bianca, Hoylaerts Marc F, Gallacher David J, Rong Lu Hua, Himmelreich Uwe, D'hooge Jan, Swinnen Melissa, Lijnen Henri R
Abstract excerpt
Rosiglitazone ((RS)-5-[4-(2-[methyl(pyridin-2-yl)amino]ethoxy)benzyl]thiazolidine-2,4-dione, RGZ)-induced adverse drug effects in diabetic patients were not adequately predicted by current preclinical rodent models. Therefore, we have used the Akita mouse with genetic predisposition to diabetes to unravel the underlying molecular mechanisms. The effect of RGZ on adipose tissue and on cardiac function was...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
